Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
BackgroundBunce, M., O'Neill, C. M., Barnardo, M. C. N. M., Krausa, P., Browning, M. J., Morris, P. J., & Welsh, K. I. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb03127.x · Cited by 997 · cited 1×
“copies/ml). Blood samples were also obtained from healthy adult volunteers. Peripheral blood mononuclear cells (PBMCs) were separated from heparinised blood and cryopreserved for subsequent studies. HLA typing was carried out by amplification refractory mutation system–polymerase chain reaction (ARMS–PCR) using sequen…”
MethodPersistent immune activation in HIV-1 infection is associated with progression to AIDS
Hazenberg, M. D., Otto, S. A., van Benthem, B. H., Roos, M. T., Coutinho, R. A., Lange, J. M., Hamann, D., Prins, M., & Miedema, F. (2003) · AIDS · doi:10.1097/00002030-200309050-00006 · Cited by 773
Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J. A., Sinclair, A. J., Nayak, L., & Moss, P. A. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1984 · Cited by 754 · cited 1×
“CMV may therefore play an important role in the decline of the immune resources, as recently proposed in the HIV-noninfected elderly (Khan et al. 2002; Wikby et al. 2002).”
BackgroundRufer, N., Brümmendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., & Lansdorp, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.157 · Cited by 709
Self-citationMaturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA
Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., & Lanzavecchia, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.821 · Cited by 709 · cited 1×
“T-cells using human material. We used a range of concentrations of the melan-A antigen loaded onto professional antigen-presenting cells to generate different levels of stimulation. Mature DCs do not persist very long in culture (2–3 d); moreover, the half-life of class I MHC–peptide complexes on mature DCs is rather…”
MethodSelf-citationPD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
Carter, L. L., Fouser, L. A., Jussif, J., Fitz, L., Deng, B., Wood, C. R., Collins, M., Honjo, T., Freeman, G. J., & Carreno, B. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9 · Cited by 673
The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses
Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660 · cited 1×
“, CD4þ Tcells and antigen-presenting cells) (Kalams and Walker 1998) may explain the failure of antiviral immunity to eradicate the virus.”
BackgroundSilvestri, G., Sodora, D. L., Koup, R. A., Paiardini, M., O'Neil, S. P., McClure, H. M., Staprans, S. I., & Feinberg, M. B. (2003) · Immunity · doi:10.1016/s1074-7613(03)00060-8 · Cited by 645
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 593 · cited 1×
“…infection (Wolthers et al. 1996b; Appay et al. 2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al. 1995; Hellerstein et al. 1999, 2003), which reflect a diminished capacity to renew the pool of T-cells.”
BackgroundPhenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.
Altman, J. D., Moss, P. A. H., Goulder, P., Barouch, D. H., McHeyzer‐Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (2011) · PubMed · Cited by 572
Self-citationTelomere length dynamics in human lymphocyte subpopulations measured by flow cytometry
Rufer, N., Dragowska, W., Thornbury, G., Roosnek, E., & Lansdorp, P. M. (1998) · Nature Biotechnology · doi:10.1038/nbt0898-743 · Cited by 552 · cited 1×
“the telomeres by approximately 30–60 basespairs (Rufer et al. 1998), until the cells lose their capacity to proliferate any”
BackgroundSelf-citationViral mechanisms of immune evasion
Alcami, A., & Koszinowski, U. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01699-6 · Cited by 548 · cited 1×
“In common with the majority of persistent viruses, HIV has developed a number of strategies to evade host immunity (Alcami and Koszinowski 2000).”
BackgroundReplicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547 · cited 1×
“This may not be dissimilar to the changes in gene expression that occur during replicative senescence in fibroblasts (Smith and Pereira-Smith 1996).”
BackgroundCharacterization of CD4+ CTLs Ex Vivo
Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P., Grey, P., Smith, D., McMichael, A. J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5954 · Cited by 545
Self-citationSousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., & Victorino, R. M. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3400 · Cited by 507
CD8 naive T cell counts decrease progressively in HIV-infected adults.
Roederer, M., Dubs, J. G., Anderson, M. T., Raju, P. A., Herzenberg, L. A., & Herzenberg, L. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117892 · Cited by 489 · cited 1×
“1998) and reduced naı̈ve T-cell numbers (Roederer et al. 1995; Hellerstein et al. 1999, 2003), which reflect a diminished capacity to renew the pool of T-cells.”
BackgroundEffros, R. B., Allsopp, R., Chiu, C.-P., Hausner, M. A., Hirji, K., Wang, L., Harley, C. B., Villeponteau, B., West, M. D., & Giorgi, J. V. (1996) · AIDS · doi:10.1097/00002030-199607000-00001 · Cited by 457 · cited 1×
“), but for others, these cells have lost their capacity to proliferate and their incidence may reflect ageing of the lymphocyte population (”
BackgroundCD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?
Grossman, Z., Meier-Schellersheim, M., Sousa, A. E., Victorino, R. M. M., & Paul, W. E. (2002) · Nature Medicine · doi:10.1038/nm0402-319 · Cited by 450 · cited 4×
“They may reflect a premature decline of the immune resources necessary for viral control and therefore contribute to the onset of disease progression (Effros 2000; Hazenberg et al. 2000a; Appay and Rowland-Jones 2002b; Grossman et al. 2002).”
BackgroundInfluentialHazenberg, M. D., Stuart, J. W. T. C., Otto, S. A., Borleffs, J. C. C., Boucher, C. A. B., de Boer, R. J., Miedema, F., & Hamann, D. (2000) · Blood · doi:10.1182/blood.v95.1.249 · Cited by 450
Giorgi, J. V., Liu, Z., Hultin, L. E., Cumberland, W. G., Hennessey, K. A., & Detels, R. (1993) · PubMed · Cited by 443
Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells
Barber, D. L., Wherry, E. J., & Ahmed, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.27 · Cited by 443
Gamadia, L. E., Remmerswaal, E. B. M., Weel, J. F., Bemelman, F., van Lier, R. A. W., & Ten Berge, I. J. M. (2003) · Blood · doi:10.1182/blood-2002-08-2502 · Cited by 422
Wikby, A. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00212-1 · Cited by 414 · cited 1×
“CMV may therefore play an important role in the decline of the immune resources, as recently proposed in the HIV-noninfected elderly (Khan et al. 2002; Wikby et al. 2002).”
BackgroundHazenberg, M. D., Otto, S. A., Stuart, J. W. T. C., Verschuren, M. C. M., Borleffs, J. C. C., Boucher, C. A. B., Coutinho, R. A., Lange, J. M. A., de Wit, T. F. R., Tsegaye, A., et al. (2000) · Nature Medicine · doi:10.1038/79549 · Cited by 394 · cited 4×
“Naı̈ve cells exhibited a slight increase in Ki67 (proliferation marker) expression during acute infection (p = 0.03), in keeping with activation-related proliferation of this subset, as previously described (Hazenberg et al. 2000b).”
BackgroundResultInfluentialAgeing of lymphocytes and lymphocytes in the aged
Globerson, A., & Effros, R. B. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01714-x · Cited by 309
T Cell Telomere Length in HIV-1 Infection: No Evidence for Increased CD4 + T Cell Turnover
Wolthers, K. C., Bea, G., Wisman, A., Otto, S. A., de Roda Husman, A.-M., Schaft, N., de Wolf, F., Goudsmit, J., Coutinho, R. A., van der Zee, A. G. J., et al. (1996) · Science · doi:10.1126/science.274.5292.1543 · Cited by 286 · cited 2×
“…to elevated T-cell turnover and an increase in the proportion of highly differentiated antigen-experienced CD8þ and CD4þ Tcells during HIV infection (Wolthers et al. 1996b; Appay et al. 2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced…”
BackgroundCytomegalovirus Infection and HIV-1 Disease Progression in Infants Born to HIV-1–Infected Women
Kovacs, A., Schluchter, M., Easley, K., Demmler, G., Shearer, W., Russa, P. L., Pitt, J., Cooper, E., Goldfarb, J., Hodes, D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410203 · Cited by 279
The Influence of Human Immunodeficiency Virus-1 on Hematopoiesis
Moses, A., Nelson, J., & Bagby, G. C. (1998) · Blood · doi:10.1182/blood.v91.5.1479 · Cited by 277 · cited 1×
“2003) as well as the failure of the bone marrow and the reduction of primitive hemaopoietic stem cell subsets (Marandin et al. 1996; Moses et al. 1998), as observed in HIV-1-infected individuals.”
BackgroundBroussard, S. R., Staprans, S. I., White, R., Whitehead, E. M., Feinberg, M. B., & Allan, J. S. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2262-2275.2001 · Cited by 243 · cited 1×
“This is supported by studies of sooty mangabeys and African green monkeys, the natural hosts of simian immunodeficiency virus (SIV), which survive SIV infection and are characterised by low immune activation, in striking contrast to rhesus macaques, for which SIV infection is fatal (Kaur et al. 1998; Broussard et al.…”
ResultSubpopulations of long-lived and short-lived T cells in advanced HIV-1 infection
Hellerstein, M. K., Hoh, R., Hanley, M. B., Cesar, D., Lee, D. C., Neese, R. A., & McCune, J. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17533 · Cited by 243
Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions
Tesselaar, K., Arens, R., van Schijndel, G. M. W., Baars, P. A., van der Valk, M. A., Borst, J., van Oers, M. H. J., & van Lier, R. A. W. (2003) · Nature Immunology · doi:10.1038/ni869 · Cited by 235 · cited 1×
“This hypothesis is also strongly supported by a recent study performed in a mouse model in which persistent immune activation was shown to exhaust the T-cell pool and be sufficient to induce lethal immunodeficiency (Tesselaar et al. 2003).”
ResultAmyes, E., Hatton, C., Montamat-Sicotte, D., Gudgeon, N., Rickinson, A. B., McMichael, A. J., & Callan, M. F. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022058 · Cited by 225 · cited 1×
“Interestingly, a similar phenomenon seems to happen in the context of CD4þ T-cells, as CMV-specific CD4þ T-cells show further differentiation, in comparison with EBV-specific CD4þ T-cells (Amyes et al. 2003).”
ResultSelf-citationWebster, A., Cook, D. G., Emery, V. C., Lee, C. A., Grundy, J. E., Kernoff, P. B. A., & Griffiths, P. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90312-7 · Cited by 221 · cited 1×
“2003); it has also been shown to be a cofactor for HIV disease progression and death in some longitudinal studies of HIV-infected haemophiliacs (Webster et al. 1989).”
BackgroundSelf-citationZhang, D., Shankar, P., Xu, Z., Harnisch, B., Chen, G., Lange, C., Lee, S. J., Valdez, H., Lederman, M. M., & Lieberman, J. (2003) · Blood · doi:10.1182/blood-2002-03-0791 · Cited by 189
Faces and phases of human CD8+ T-cell development
Hamann, D., Roos, M. T. L., & van Lier, R. A. W. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01444-9 · Cited by 179
Premature ageing of the immune system: the cause of AIDS?
Appay, V., & Rowland-Jones, S. L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02338-4 · Cited by 173
Self-citationKaur, A., Grant, R. M., Means, R. E., McClure, H. M., Feinberg, M. B., & Johnson, R. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9597-9611.1998 · Cited by 161 · cited 2×
“…African green monkeys, the natural hosts of simian immunodeficiency virus (SIV), which survive SIV infection and are characterised by low immune activation, in striking contrast to rhesus macaques, for which SIV infection is fatal (Kaur et al. 1998; Broussard et al. 2001; Silvestri et al. 2003).”
BackgroundKalayjian, R. C., Landay, A., Pollard, R. B., Taub, D. D., Gross, B. H., Francis, I. R., Sevin, A., Pu, M., Spritzler, J., Chernoff, M., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/375372 · Cited by 158 · cited 1×
“In addition to a direct effect of HIV on the thymus, decreased thymic output and T-cell renewal may originate from thymus involution (Kalayjian et al. 2003) as well as the failure of the bone marrow and the reduction of primitive hemaopoietic stem cell subsets (Marandin et al. 1996; Moses et al.…”
BackgroundWang, E. C., Moss, P. A., Frodsham, P., Lehner, P. J., Bell, J. I., & Borysiewicz, L. K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5046 · Cited by 156 · cited 1×
“For instance, CMV is known to drive substantial differentiation of T-cells towards CD57þ cells (Wang et al. 1995).”
BackgroundNociari, M. M., Telford, W., & Russo, C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3327 · Cited by 153
Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans
Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K., Valmori, D., Liénard, D., Plum, J., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011658 · Cited by 152
Self-citationDynamics of T Cell Responses in HIV Infection
Appay, V., Papagno, L., Spina, C. A., Hansasuta, P., King, A., Jones, L., Ogg, G. S., Little, S., McMichael, A. J., Richman, D. D., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3660 · Cited by 150
Self-citationProliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T Cells
van Leeuwen, E. M., Gamadia, L. E., Baars, P. A., Remmerswaal, E. B., ten Berge, I. J., & van Lier, R. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5838 · Cited by 147 · cited 2×
“It was previously reported that antigen-specific CD27 CD8þ T-cells do proliferate (van Leeuwen et al. 2002).”
BackgroundDunne, P. J., Faint, J. M., Gudgeon, N. H., Fletcher, J. M., Plunkett, F. J., Soares, M. V. D., Hislop, A. D., Annels, N. E., Rickinson, A. B., Salmon, M., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0160 · Cited by 144
Telomerase levels control the lifespan of human T lymphocytes
Röth, A., Yssel, H., Pène, J., Chavez, E. A., Schertzer, M., Lansdorp, P. M., Spits, H., & Luiten, R. M. (2003) · Blood · doi:10.1182/blood-2002-07-2015 · Cited by 135 · cited 1×
“), until the cells lose their capacity to proliferate any longer. The induction of human telomerase expression (necessary for the maintenance of telomere length) has recently been shown to decrease in T-cells that have expanded in vivo upon antigen encounter (”
BackgroundFailing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue
van Baarle, D., Kostense, S., van Oers, M. H. J., Hamann, D., & Miedema, F. F. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02326-8 · Cited by 119 · cited 3×
“For instance, van Baarle et al. (2002a) reported a correlation between high numbers of latedifferentiated HIV-specific CD8þ T-cells and years of AIDSfree survival.”
BackgroundResultDynamics of CD4 and CD8 T Cell Responses to Cytomegalovirus in Healthy Human Donors
Dunn, H. S., Haney, D. J., Ghanekar, S. A., Stepick‐Biek, P., Lewis, D. B., & Maecker, H. T. (2002) · The Journal of Infectious Diseases · doi:10.1086/341079 · Cited by 117 · cited 1×
“Data have indicated that frequent reactivation of CMV likely occurs in the human host, as evidenced by the presence of a large population of CD69þ CMV-specific cells, indicative of recent in vivo activation (Dunn et al. 2002).”
BackgroundAppay, V., & Rowland‐Jones, S. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00195-3 · Cited by 109
Self-citationSpeiser, D. E., Liénard, D., Pittet, M. J., Batard, P., Rimoldi, D., Guillaume, P., Cerottini, J.-C., & Romero, P. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200203)32:3<731::aid-immu731>3.0.co;2-h · Cited by 104 · cited 1×
“]) are able to express high perforin levels after certain conditions of stimulation. In contrast, the high perforin levels observed in resting late-differentiated T-cells seem to correlate with characteristics of replicative senescence. These findings challenge the view that highly differentiated T-cells are beneficia…”
BackgroundDutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P.-Y., Legal, F. A., Guillaume, P., Romero, P., Cerottini, J.-C., Houghten, R. A., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020242 · Cited by 99 · cited 1×
“T-cells (reactive for the HLA-A2-restricted melan-A antigen [”
Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals
Yao, Q. Y., Tierney, R. J., Croom-Carter, D. S. G., Dukers, D. F., Cooper, G., Ellis, C. J., Rowe, M., & Rickinson, A. B. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.4884-4894.1996 · Cited by 99 · cited 1×
“During acute HIV-1 infection, immunosuppression may develop that favours the replication of host flora like CMV and EBV, as occurs in other immunocompromised individuals (Yao et al. 1996; Gerna et al. 1998).”
BackgroundAccelerated replicative senescence of the peripheral immune system induced by HIV infection
Bestilny, L. J., Gill, M. J., Mody, C. H., & Riabowol, K. T. (2000) · AIDS · doi:10.1097/00002030-200005050-00002 · Cited by 95
Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection
Marandin, A., Katz, A., Oksenhendler, E., Tulliez, M., Picard, F., Vainchenker, W., & Louache, F. (1996) · Blood · doi:10.1182/blood.v88.12.4568.bloodjournal88124568 · Cited by 87 · cited 1×
“2003) as well as the failure of the bone marrow and the reduction of primitive hemaopoietic stem cell subsets (Marandin et al. 1996; Moses et al. 1998), as observed in HIV-1-infected individuals.”
BackgroundGiovannetti, A., Mazzetta, F., Caprini, E., Aiuti, A., Marziali, M., Pierdominici, M., Cossarizza, A., Chessa, L., Scala, E., Quinti, I., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0976 · Cited by 82 · cited 1×
“Interestingly, these characteristics are not unique to HIV infection, but they are also common to other conditions that result in some degree of immunodeficiency, like ataxia telangiectasia (Giovannetti et al. 2002), and normal human ageing (Nociari et al.”
BackgroundWolthers, K. C., Otto, S. A., Lens, S. M. A., Kolbach, D. N., van Lier, R. A. W., Miedema, F. F., & Meyaard, L. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260806 · Cited by 74 · cited 3×
“…to elevated T-cell turnover and an increase in the proportion of highly differentiated antigen-experienced CD8þ and CD4þ Tcells during HIV infection (Wolthers et al. 1996b; Appay et al. 2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced…”
BackgroundSalio, M., Shepherd, D., Dunbar, P. R., Palmowski, M., Murphy, K., Wu, L., & Cerundolo, V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1188 · Cited by 71 · cited 2×
“In vitro priming of CD8þ T-cells with DCs. DCs were generated as previously described (Salio et al. 2001).”
BackgroundMethodSelf-citationErice, A., Tierney, C., Hirsch, M., Caliendo, A. M., Weinberg, A., Kendall, M. A., & Polsky, B. (2003) · Clinical Infectious Diseases · doi:10.1086/375843 · Cited by 67 · cited 1×
“1999) and with reduced survival in patients with advanced HIV disease (Erice et al. 2003); it has also been shown to be a cofactor for HIV disease progression and death in some longitudinal studies of HIV-infected haemophiliacs (Webster et al.”
Backgroundvan Baarle, D., Kostense, S., Hovenkamp, E., Ogg, G., Nanlohy, N., Callan, M. F., Dukers, N. H., McMichael, A. J., van Oers, M. H., & Miedema, F. (2002) · AIDS · doi:10.1097/00002030-200210180-00004 · Cited by 66
Self-citationTussey, L. G., Nair, U. S., Bachinsky, M., Edwards, B. H., Bakari, J., Grimm, K., Joyce, J., Vessey, R., Steigbigel, R., Robertson, M. N., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/367707 · Cited by 64
Heintel, T., Sester, M., Rodríguez, M. M. B., Krieg, C., Sester, U., Wagner, R., Pees, H. W., Gärtner, B., Maier, R., & Meyerhans, A. (2002) · AIDS · doi:10.1097/00002030-200207260-00006 · Cited by 49 · cited 1×
“In keeping with this position, the fraction of perforin HIVspecific CD8þ T-cells has been proposed to be a marker for disease progression (Heintel et al. 2002).”
BackgroundEffros, R. B. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00283-5 · Cited by 34
Gerna, G., Percivalle, E., Baldanti, F., Sarasini, A., Zavattoni, M., Furione, M., Torsellini, M., & Revello, M. G. (1998) · PubMed · Cited by 24
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Climate Change and Infectious Diseases: From Evidence to a Predictive Framework
Altizer, S., Ostfeld, R. S., Johnson, P. T. J., Kutz, S., & Harvell, C. D. (2013) · Science · doi:10.1126/science.1239401 · Cited by 1,292
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
“The incidence of IFN-γ+perforinhigh HIV-specific CD8+ T cells has been reported to correlate with HIV-1 disease progression (49, 50).”
BackgroundSystemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 868
“…the frequency of HIVspecific T cells is only a small proportion of the activated cell population, suggesting other less-direct mechanisms) (Papagno et al., 2004); (2) other pathogens—including common herpes viruses such as CMV—contribute to high level T cell activation, although why the…”
InfluentialAdoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
The Influence of Age on T Cell Generation and TCR Diversity
Naylor, K., Li, G., Vallejo, A. N., Lee, W.-W., Koetz, K., Bryl, E., Witkowski, J., Fulbright, J., Weyand, C. M., & Goronzy, J. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7446 · Cited by 802
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.